OncoDecipher vs Prism AI
OncoDecipher vs Prism AI, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: OncoDecipher is on 43/100 and Prism AI on 48/100.
Where each one leads
OncoDecipher
Leads on none of the measures we hold for both companies.
Prism AI
- our overall score: 48/100 against 43/100
- funding raised: $12.0M against $1.0M
At a glance
| Measure | OncoDecipher | Prism AI |
|---|---|---|
| What it is | OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. | AI platform for discovering complex multi-omics signatures for personalized medicine. |
| Category | Life Sciences, Cancer, Oncology, Mutation | Life Sciences, Drug Development, Biomarkers, Genomics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2015 | 2024 |
| Headquarters | Cambridge, United States | San Francisco, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | OncoDecipher | Prism AI |
|---|---|---|
| Employees | Not published | 4 |
| Headcount growthLast 12 months | Not published | +35.9% |
| Total funding | $1.0M | $12.0M |
| Latest round | Seed | Bootstrapped |
| LinkedIn followers | Not published | 1,248 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | OncoDecipher | Prism AI |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 48/100 |
| Traction | 30/100 | 42/100 |
| Team | 60/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 3/100 | 37/100 |
| Quality | 52/100 | 48/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (41/100) |
| Domain ratingLink authority, 0-100 | Not published | 9/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | OncoDecipher | Prism AI |
|---|---|---|
| CMS | Not detected | Wix |
OncoDecipher vs Prism AI: common questions
Which is better, OncoDecipher or Prism AI?
On our 0-100 score Prism AI rates higher (48/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do OncoDecipher and Prism AI compare on the numbers?
Prism AI leads on our overall score (48/100 against 43/100), funding raised ($12.0M against $1.0M).
Read the full OncoDecipher review and pricing or the Prism AI review and pricing. You can also browse other OncoDecipher alternatives we track.